Biogen reported that the company’s gene therapy, cotoretigene toliparvovec, failed to hit the primary endpoint of the Phase II/III XIRIUS trial for X-linked retinitis pigmentosa (XLRP).
If you are not happy with the results below please do another search
50 search results for:
PerkinElmer Inc. expanded the company’s presence in cell biology with the $260 million acquisition of Massachusetts-based Nexcelom Bioscience.
Prime Minister Narendra Modi sounded the alarm over the rapid spread of Covid-19 through India’s vast countryside on May 14, as 4,000 people died from the virus for the third straight day and total infections crossed 24 million.
The origin of the novel coronavirus is still unclear and the theory that it was caused by a laboratory leak needs to be taken seriously until there is a rigorous data-led investigation that proves it wrong, a group of leading scientists said.
Michael Costello was named SVP, Group Creative Director of Copy at INVIVO BRANDS, an independent advertising agency with a focus on health and wellness.
A first-of-its-kind organization launched on May 13 unifying the voices of life science companies committed to delivering desperately needed treatments to rare disease patients. The Rare Disease Company Coalition’s 10 founding members have brought 22 treatments to market and have more than 160 rare disease programs in the works.
The U.S. Centers for Disease Control and Prevention (CDC) on May 13 advised that fully vaccinated people do not need to wear masks outdoors and can avoid wearing them indoors in most places, updated guidance the agency said will allow life to begin to return to normal.
Pfizer’s Covid-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said.
Pivotal data from Amgen’s and AstraZeneca’s NAVIGATOR Phase III trial show tezepelumab, a potential first-in-class human monoclonal antibody, reduced asthma aggravations and exacerbations requiring hospitalizations better than placebo in patients with severe asthma.
A new film produced by health creative agency The Bloc exposes the legacy of racial trauma. “Skindeep” is phase II of The Bloc’s series on racial trauma in America, taking a deeper look at the PTSD caused by the country’s divide.